Medicinal – Page 172

Rac1/PAK1 signaling contributes to bone cancer pain by regulation dendritic spine remodeling in rats

mycolabadmin

Researchers studied how bone cancer pain develops in rats and found that a specific cellular signaling pathway called Rac1/PAK1 plays a key role. When tumors grow in bone, this pathway becomes overactive and causes changes in nerve cell structures called dendritic spines, which leads to increased pain sensitivity. By blocking this pathway with a drug called NSC23766, scientists were able to reduce pain and reverse the harmful changes to nerve cells, suggesting a new potential treatment approach for cancer patients suffering from bone pain.

Overexpression of efflux pump and biofilm associated genes in itraconazole resistant Candida albicans isolates causing onychomycosis

mycolabadmin

This study examined why some fungal nail infections caused by Candida albicans don’t respond to itraconazole treatment. Researchers found that resistant fungi have higher levels of genes that pump the antifungal drug out of their cells and genes that help them form protective biofilm layers. These findings suggest that combining itraconazole with drugs that block these pumps or disrupt biofilms could be more effective for treating stubborn fungal nail infections.

Exploring the Mechanisms of Amino Acid and Bioactive Constituent Formation During Fruiting Body Development in Lyophyllum decastes by Metabolomic and Transcriptomic Analyses

mycolabadmin

This study examined how Lyophyllum decastes mushrooms develop and build up their nutritious compounds. Researchers tracked amino acids and polysaccharides across four growth stages and identified which genes control their production. The mature mushrooms contained the highest levels of beneficial compounds, with amino acids reaching 45,107.39 μg/g and polysaccharides at 13.66 mg/g. These findings help explain why these mushrooms are nutritious and suggest ways to grow them better for maximum health benefits.

Conditional deletion of ROCK2 induces anxiety-like behaviors and alters dendritic spine density and morphology on CA1 pyramidal neurons

mycolabadmin

Researchers created mice with reduced ROCK2 protein in brain cells to understand how this protein affects behavior and brain structure. These mice showed anxiety-like behavior, avoiding open spaces and preferring darkness. The study found that ROCK2 affects the structure of dendritic spines, which are tiny branches on nerve cells that allow communication between neurons, particularly in the hippocampus region involved in learning and memory.

Design and Evaluation of a Inonotus obliquus–AgNP–Maltodextrin Delivery System: Antioxidant, Antimicrobial, Acetylcholinesterase Inhibitory and Cytotoxic Potential

mycolabadmin

Researchers studied Chaga mushroom from Romania and developed new ways to package and deliver its beneficial compounds using silver nanoparticles and a food-safe ingredient called maltodextrin. These new delivery systems were designed to work better in the body by improving how well the mushroom’s active ingredients dissolve and stay stable. Testing showed these enhanced formulations were very effective at fighting bacteria, protecting cells from damage, and killing cancer cells.

Graphene nanomaterials: A new frontier in preventing respiratory fungal infections

mycolabadmin

Scientists are exploring nano-graphene oxide, a microscopic material made from graphene, as a new treatment for serious lung fungal infections. These tiny particles can kill fungal cells through multiple mechanisms and deliver antifungal drugs directly to infection sites while reducing harmful side effects. Researchers found that graphene oxide can be combined with existing antifungal medications to make them work better and even help overcome drug-resistant fungal infections.

Exploring the Anticancer Potential of Coriolus versicolor in Breast Cancer: A Review

mycolabadmin

Coriolus versicolor, also known as turkey tail mushroom, has been used in traditional Chinese medicine for thousands of years. Recent scientific research shows it may help fight breast cancer through multiple mechanisms: killing cancer cells directly through programmed cell death pathways, breaking down the estrogen that fuels some breast cancers, preventing cancer spread, and boosting the immune system. While early studies are promising and one clinical trial showed good safety and immune benefits, larger studies are needed before this mushroom can be recommended as an official cancer treatment.

Itraconazole resistance in Madurella fahalii linked to a distinct homolog of the gene encoding cytochrome P450 14-α sterol demethylase (CYP51)

mycolabadmin

A fungal infection called mycetoma caused by Madurella fahalii doesn’t respond to a common antifungal drug called itraconazole. Researchers discovered that this fungus has an extra gene that produces a protein that resists the drug, which isn’t found in a similar fungus that remains susceptible. This finding could help develop better treatments for mycetoma patients in the future.

Breaking the mould: challenging the status quo of clinical trial response definitions for invasive fungal diseases—a debate

mycolabadmin

Doctors and researchers use standard definitions to determine if antifungal treatments work in clinical trials. This debate examines whether the standards created in 2008 are still appropriate today. Key concerns include whether stable disease should always count as treatment failure, how to handle deaths from other causes, and whether newer testing methods should be incorporated. The expert panel concluded these definitions need updating to reflect modern treatment options and patient needs.

Phallus indusiatus Extracts Promoted MCF-7 Apoptosis Under TNFα-induced Tumor Microenvironment by Attenuating NF-kappaB and Akt Activation

mycolabadmin

Bamboo mushroom extracts show promise in helping treat breast cancer by making cancer cells more sensitive to chemotherapy drugs. The mushroom reduces inflammation and blocks protective signals in cancer cells, making them more likely to die. This research suggests bamboo mushroom could be a helpful supplement for breast cancer patients, especially when used alongside standard cancer treatments.

Research Topic: Medicinal